Updated April 2, 2014, at 3:10 p.m. EST with comments from Baxter.
Malta regulators announced this week that healthcare titan Baxter (NYSE:BAX) plans to add 30 additional jobs in the country.
Baxter will add new members to its research & development workforce over the next 18 months and plans to further invest in infrastructure at the Malta facility, a Baxter spokesperson confirmed with MassDevice.com today.
"The new positions will consist of engineers who will operate in different technical disciplines on products in Baxter’s Medical Products business, complementing other existing R&D resources around the world," the spokesperson said. "Baxter is also investing in its manufacturing infrastructure and employee capabilities to meet current and future business needs while increasing manufacturing capacity over the coming years."
The additions wouldn’t make up for the nearly 100 workers that were reportedly cut from the Malta office around this time last year. The Times of Malta reported in March 2013 that Baxter planned to dismiss 97 employees, representing about 16% of Baxter’s workforce in Malta at the time.
Many of those jobs moved to Tunisia, according to the report.
The news comes amid a major overhaul for Baxter, which is following in the footsteps of some other healthcare giants in deciding to split its medical products and pharmaceuticals businesses.
BAX shares were down 0.5% today, trading at $73.29 as of about 12:45 p.m.
